多学科瘤委员会讨论是否与增加5年生存率相关? 一个元分析研究研究
Ghada Algwaiz1, Yezan Salam2, Rami Bustami3
1Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Global journal on quality and safety in healthcare
|June 1, 2023
概括
多学科瘤板 (MTBs) 显著提高了癌症患者5年生存率. 这些协作会议通过优化护理协调和治疗途径来提高患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 医疗保健管理的管理
- 生物统计学 生物统计学
背景情况:
- 癌症护理的复杂性需要协调医疗保健提供者的投入.
- 多学科瘤委员会 (MTBs) 旨在优化患者护理计划,以改善结果.
- 由于资源投资,评估MTB会议的经验效益至关重要.
研究的目的:
- 评估多学科瘤委员会 (MTB) 会议对患者5年生存率的影响.
- 综合现有的关于MTB在癌症患者护理中的有效性的文献.
主要方法:
- 对1995年1月至2019年7月期间发表的研究进行了元分析.
- 在Ovid MEDLINE和Embase数据库中进行文献搜索.
- 包括的研究评估了MTB讨论的病例中的5年生存率,并进行了比较或预测/后测设计.
主要成果:
- 五项研究符合纳入标准;质量受到偏见和历史队列的影响.
- 摩托车会议与显著改善的5年生存率有关.
- 在MTB组中,5年死亡率的几率比率为0.59 (CI 0.45-0.78,p < 0.001).
结论:
- 癌症多学科瘤板 (MTBs) 表明对患者5年生存期有显著的积极影响.
- 改善结果的潜在原因包括更快地开始治疗,更好地遵守指南,并减少并发症.
- 需要进一步的前性研究来阐明机制并优化MTB的好处.
相关概念视频
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:20Comparing the Survival Analysis of Two or More Groups
229
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
229
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K